The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between state Medicaid policies and accrual of Black participants to cancer clinical trials.
 
Samuel U Takvorian
Stock and Other Ownership Interests - Bluebird Bio (I); Gilead Sciences (I); Johnson & Johnson (I); Merck (I); Novartis (I); Pfizer (I); Pfizer (I); Portola Pharmaceuticals (I)
Consulting or Advisory Role - AstraZeneca/Merck; Boehringer Ingelheim (I); Genentech; Health Advances; Novartis (I); Novocure (I)
Research Funding - AstraZeneca (I); Lilly (I); Pfizer; Trizell (I)
 
Paula Chatterjee
No Relationships to Disclose
 
Ronac Mamtani
Honoraria - Flatiron Health
Consulting or Advisory Role - Genentech/Roche; Seattle Genetics/Astellas
Research Funding - Merck
 
Yaxin Wu
No Relationships to Disclose
 
Carmen Guerra
Leadership - Freenome; Genentech; GlaxoSmithKline; GRAIL; Guardant Health
Stock and Other Ownership Interests - BEAM Therapeutics; crispr therapeutics; Editas Medicine; Intellia Therapeutics
Honoraria - Lundbeck (I)
Consulting or Advisory Role - EB Squibb (I)
Speakers' Bureau - Janssen (I); Pfizer (I)
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Janssen (I); Lundbeck (I)
(OPTIONAL) Uncompensated Relationships - Tapestry Networks; Tapestry Networks
 
Rachel M. Werner
No Relationships to Disclose
 
William Schpero
No Relationships to Disclose